Indeed, in this significant cohort, loss of EphB2 expression correlated with an unfavorable tumor phenotype, with advanced tumor stage, high grade, presence of vascular invasion, infiltrative tumor growth, nodal metastasis, and poor survival (125). The gene discussed is EPHB2; the disease is neoplasm.